Valuation: ALTEOGEN Inc.

Capitalization 27,704B 18.8B 16.21B 15.09B 14.05B 26.15B 1,706B 28.14B 174B 68.43B 814B 70.5B 69.05B 2,971B P/E ratio 2025 *
382x
P/E ratio 2026 * 67.5x
Enterprise value 27.64B 18.76M 16.17M 15.05M 14.02M 26.09M 1.7B 28.08M 173M 68.28M 812M 70.35M 68.9M 2.96B EV / Sales 2025 *
116x
EV / Sales 2026 * 53.1x
Free-Float
72.75%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day+10.10%
1 week+8.25%
Current month+15.24%
1 month+18.81%
3 months+16.40%
6 months+10.45%
Current year+15.24%
More quotes
1 week 445,500
Extreme 445500
529,000
1 month 413,500
Extreme 413500
529,000
Current year 445,500
Extreme 445500
529,000
1 year 304,500
Extreme 304500
569,000
3 years 31,950
Extreme 31950
569,000
5 years 27,875
Extreme 27875
569,000
10 years 3,645.83
Extreme 3645.8333
569,000
More quotes
Manager TitleAgeSince
Comptroller/Controller/Auditor 60 2021-03-28
Corporate Officer/Principal 60 -
Director TitleAgeSince
Chairman 71 2008-05-12
Director/Board Member 69 2021-03-28
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+10.10%+8.25%+70.68%+1,369.50% 17.14B
-1.20%-7.97%+5.74%+0.68% 76.12B
-0.92%+94.70%+94.70%+94.70% 61.96B
+2.35%+5.19%+39.57%+233.17% 57.24B
+0.14%+0.62%-36.48%-37.97% 56.7B
-2.46%-12.37%+16.42%-43.22% 24.73B
+0.92%-0.62%+46.56%+30.70% 20.66B
+0.56%+0.56%+167.56%+112.34% 19.8B
+6.28%+21.95%+23.90%-78.06% 15.38B
0.00%-1.28%+123.57%+778.57% 14.7B
Average +1.62%+1.91%+55.22%+246.04% 36.44B
Weighted average by Cap. +0.69%+0.34%+40.01%+144.39%
See all sector performances

Financials

2025 *2026 *
Net sales 239B 162M 140M 130M 121M 225M 14.69B 242M 1.49B 589M 7.01B 607M 595M 25.58B 514B 349M 301M 280M 261M 485M 31.65B 522M 3.22B 1.27B 15.1B 1.31B 1.28B 55.12B
Net income 104B 70.43M 60.72M 56.53M 52.62M 97.98M 6.39B 105M 650M 256M 3.05B 264M 259M 11.13B 415B 282M 243M 226M 210M 392M 25.55B 422M 2.6B 1.03B 12.19B 1.06B 1.03B 44.51B
Net Debt -59.72B -40.52M -34.93M -32.52M -30.28M -56.37M -3.68B -60.65M -374M -148M -1.75B -152M -149M -6.4B -383B -260M -224M -208M -194M -361M -23.57B -389M -2.4B -946M -11.24B -974M -954M -41.05B
More financial data * Estimated data
Logo ALTEOGEN Inc.
Alteogen Inc. is a Korea-based company mainly engaged in the research and development of biopharmaceuticals. The Company operates biobetter business segment, which develops protein pharmaceuticals and cancer therapies, and bio similar business segment, which develops bio similar and animal medicines. The Company mainly provides growth hormone, herceptin, humira, antibodies, animal drugs and others.
Employees
159
More about the company
Date Price Change Volume
26-01-15 518,000.00 +10.10% 2,365,657
26-01-15 470,500.00 +0.75% 287,350
26-01-14 467,000.00 -2.20% 356,764
26-01-13 477,500.00 +0.42% 508,943
26-01-12 475,500.00 -6.95% 740,896

End-of-day quote Korea S.E., January 15, 2026

More quotes
Trader
Investor
Global
Quality
ESG MSCI
CCC
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
518,000.00KRW
Average target price
522,000.00KRW
Spread / Average Target
+0.77%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. A196170 Stock